Ebosin

依博素

Report date: 2025/04/07 15:07:16

Base Information

Drug NameEbosin
Drug Alias NameN/A
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Juvenile
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical SciencesSichuan Hengxing Biomedicine Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Juvenile

Other Information

ATC CodeN/A
Related LinksN/A